Search - tctmd.com

Displaying 261 - 280 of 375

Sort: Relevancy | Date

Presentation TCT 2014

TCT 191: Health-Related Quality of Life, Functional Status, and Myocardial Ischemia in Patients with Successful Chronic Total Occlusion Recanalization

Presenter: David E. Kandzari, Maarten J. Suttorp, Richard R. Heuser, Ester Bajo

September 13, 2014

Presentation TCT 2014

TCT 190: Percutaneous Coronary Intervention Versus Medical Therapy for Coronary Chronic Total Occlusion: Results from the Italian Registry of Chronic Total Occlusion (IRCTO)

Presenter: David E. Kandzari, Maarten J. Suttorp, Richard R. Heuser, Salvatore Tomasello

September 13, 2014

Presentation TCT 2014

Negatory: There are Logical Reasons for Why Renal Artery Denervation Failed in SIMPLICITY HTN-3!

Presenter: Sanjay Kaul, Ajay J. Kirtane, David E. Kandzari

September 13, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation Therapy

September 13, 2014

News Industry News

Medtronic NC Euphora(TM) Coronary Balloon Receives FDA Clearance

September 11, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Features

Denervación Renal 2.0: Marcando el Camino de la Recuperación Tras el Symplicity HTN-3

June 24, 2014

News Features

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

June 18, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

News Conference News ACC 2014

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Yael L. Maxwell

March 31, 2014

News Conference News ACC 2014

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

Jason Kahn

March 31, 2014

News Conference News ACC 2014

No Impact on Safety Seen at Hospitals Performing PCI with No Surgical Backup

L.A. McKeown

March 30, 2014

News Conference News ACC 2014

TAVR With the CoreValve Device Superior to Surgery at 1 Year

Yael L. Maxwell

March 29, 2014

News Conference News ACC 2014

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

Yael L. Maxwell

March 29, 2014

Presentation PCI Outcomes 2014

Left Main Percutaneous Revascularization: Perspectives on Advances in Method, Outcome and Clinical Decision Making

Presenter: David E. Kandzari

March 28, 2014

Presentation CTO 2014

Management of Left Main Trifurcation Disease (with Case Examples)

Presenter: David E. Kandzari

March 01, 2014

News Daily News

Watchman获得FDA顾问小组的实质认可

Yael L. Maxwell

January 01, 2014

News Daily News

Watchman Wins Substantial Endorsement from FDA Advisory Panel

Yael L. Maxwell

January 01, 2014

News Daily News

Watchman Logra un Apoyo Importante del Panel de Asesores de la FDA

Yael L. Maxwell

January 01, 2014

Advertisement

TCT 191: Health-Related Quality of Life, Functional Status, and Myocardial Ischemia in Patients with Successful Chronic Total Occlusion Recanalization

TCT 190: Percutaneous Coronary Intervention Versus Medical Therapy for Coronary Chronic Total Occlusion: Results from the Italian Registry of Chronic Total Occlusion (IRCTO)

Negatory: There are Logical Reasons for Why Renal Artery Denervation Failed in SIMPLICITY HTN-3!

Experts Debate Future of Renal Denervation Therapy

Medtronic NC Euphora(TM) Coronary Balloon Receives FDA Clearance

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Denervación Renal 2.0: Marcando el Camino de la Recuperación Tras el Symplicity HTN-3

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

No Impact on Safety Seen at Hospitals Performing PCI with No Surgical Backup

TAVR With the CoreValve Device Superior to Surgery at 1 Year

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

Left Main Percutaneous Revascularization: Perspectives on Advances in Method, Outcome and Clinical Decision Making

Management of Left Main Trifurcation Disease (with Case Examples)

Watchman获得FDA顾问小组的实质认可

Watchman Wins Substantial Endorsement from FDA Advisory Panel

Watchman Logra un Apoyo Importante del Panel de Asesores de la FDA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content